Self-Medication Backed By EU Ministers And Parliament

18 June 1995

On June 2, European Union Health Ministers and Parliament adopted the action program on health promotion, information, education and training within the framework of public health, EU Commissioner Padraig Flynn told the 31st Annual Meeting of the European Proprietary Medicines Manufacturers' Association in Lisbon, Portugal, last week. The budget for this program has been set at 600 million Ecus ($781.4 million; see also Marketletter June 12).

This is a major step forward for the sector, and is the first time that an EU endorsement has been given to self-medication, explicitly in an official document on public health policy.

The support is not only for minor ailments, but also for chronic conditions which are initially diagnosed by the doctor and subsequently, with the right information, managed by the consumer with the help of a pharmacist. The move was welcomed by the AESGP.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight